What Phase 2 Data Tells Us to Expect The Phase 2 trial of retatrutide, published in The New England Journal of Medicine in 2023, provided an unusually clear preview of what TRIUMPH-1 might deliver
You cannot take a higher dosage 12mg/weekly
Body weight loss was observed after 10 weeks of oral semaglutide treatment in the multiple-dose trial in both healthy subjects (mean baseline body weight approximately 84 kg) and subjects with T2D (mean baseline body weight approximately 95 kg)
However, clinical trials of ferroptosis inhibitors have yielded inconsistent results, with concerns about side effects and toxicity, challenging clinical translation (Ryan et al., 2023)
Vitamin C increases glutathione levels in red blood cells and lymphocytes, while vitamin E (in mixed tocopherol form) is an important antioxidant that works alongside glutathione, aiding in its recycling (with vitamin C)